MAPT and Alzheimer disease: Besides, aneuploidy can serve as an early molecular signature of AD onset or MCI, where a chromosomal malsegregation or tetraploid state evades subsequent cell death and can lead to neuropathogenic effects such as tau phosphorylation, abnormal conformational changes or accumulation of aggregates (Arendt, 2012).